Sign in
4

Changes in Ownership

Inhibikase Therapeutics, Inc. Filed Acc 0000899243-22-028794

President and CEO bought 5,000 shares at $0.80 ($4,000)

From the SEC's structured data for this filing

Trades in this filing

Werner Milton H. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-16 Purchase : show line 1 in the form +5,000 $0.80 $4,000 5,335,433 D
Open-market purchases · 5,000 sh · avg $0.80 · $4,000
Loading xslF345X03/doc4.xml…